Knowledge of specific molecular pathways changes downstream of PTEN alteration could be helpful in optimizing molecular targeted therapy and preventative care, not only for PHTS patients, but mainly because PTEN mutations are involved in a wide range of human diseases and cancers. This evidence concerns the gene PTEN and cancer.